Cargando…
A Novel mRNA-Mediated and MicroRNA-Guided Approach to Specifically Eradicate Drug-Resistant Hepatocellular Carcinoma Cell Lines by Se-Methylselenocysteine
Despite progress in the treatment of non-visceral malignancies, the prognosis remains poor for malignancies of visceral organs and novel therapeutic approaches are urgently required. We evaluated a novel therapeutic regimen based on treatment with Se-methylselenocysteine (MSC) and concomitant tumor-...
Autores principales: | Selvam, Arun Kumar, Jawad, Rim, Gramignoli, Roberto, Achour, Adnane, Salter, Hugh, Björnstedt, Mikael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8301172/ https://www.ncbi.nlm.nih.gov/pubmed/34356326 http://dx.doi.org/10.3390/antiox10071094 |
Ejemplares similares
-
A Novel Assay Method to Determine the β-Elimination of Se-Methylselenocysteine to Monomethylselenol by Kynurenine Aminotransferase 1
por: Selvam, Arun Kumar, et al.
Publicado: (2020) -
The Effect of Methylselenocysteine and Sodium Selenite Treatment on microRNA Expression in Liver Cancer Cell Lines
por: Lendvai, Gábor, et al.
Publicado: (2020) -
Production of Se-methylselenocysteine in transgenic plants expressing selenocysteine methyltransferase
por: Ellis, Danielle R, et al.
Publicado: (2004) -
L‐Se‐methylselenocysteine sensitizes lung carcinoma to chemotherapy
por: Ma, Jia, et al.
Publicado: (2021) -
Osteopontin is a potential target gene in mouse mammary cancer chemoprevention by Se-methylselenocysteine
por: Unni, Emmanual, et al.
Publicado: (2004)